MarketPeel
Insider Trading Intelligence
CO

Curtis Gale Oltmans

FULC
CHIEF LEGAL OFFICER · FULCRUM THERAPEUTICS, INC. · CIK 0001714982
FILING MIX · LIFETIME90%/10%
BUYS
9
SELLS
1
TOTAL VALUE
$54.4K
COMPANIES
1
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
170,000
AVG SELL PX
$12.92
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Curtis Gale Oltmans, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+2.12%+0.94%+1.18%+1.18%
14d2+100.00%+1.06%+1.65%-0.58%-0.58%
30d2+50.00%-17.18%+2.04%-19.21%-19.21%
60d2+100.00%+91.53%+2.74%+88.79%+88.79%
90d2+100.00%+80.07%+1.08%+78.99%+78.99%
180d2+100.00%+14.18%+9.90%+4.28%+4.28%
1y2(1 pending)+0.00%-46.17%-9.68%-36.49%-36.49%
2y2(1 pending)+0.00%-65.26%+5.24%-70.50%-70.50%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FULC · 170,000 shares · as of Feb 2, 2026
056,250112,500168,750225,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 9 buys / 1 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
170,000170,000Feb 2, 2026Feb 4, 2026View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
Chief Legal Officer
3,452$12.92$44.6K10,252Dec 15, 2025Dec 17, 2025View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
225,000225,000Jan 24, 2025Jan 28, 2025View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000150,000Jan 26, 2024Jan 30, 2024View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
127,500127,500Apr 26, 2023Apr 28, 2023View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000150,000Feb 9, 2023Feb 13, 2023View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Aug 9, 2022Aug 11, 2022View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Jan 19, 2022Jan 21, 2022View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
SVP, General Counsel
1,088$9.01$9.8K1,088Jun 28, 2021Jun 29, 2021View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
153,600153,600Dec 3, 2020Dec 7, 2020View →
Other insiders · FULC
Loading peer insiders…
About this filer
CIK 0001714982
ROLE
Chief Legal Officer
PRIMARY
FULC
COMPANIES
1
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001714982DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback